Upcoming Congressional Hearing on Lab Test Regulation


The U.S. House of Representatives Committee on Energy and Commerce is holding a hearing entitled “Examining the Regulation of Diagnostic Tests and Laboratory Operations” on November 17 at 2pm ET (note that the date was re-scheduled from an earlier date).

The hearing will consider proposed legislation which could augment/supplant FDA’s proposal for regulating LDTs with a broader regulatory approach covering all diagnostic tests.

I haven’t read the proposed legislation yet in full, but congressional insiders claim that the bill closely follows the Diagnostic Test Working Group Proposal that was drafted by industry leaders earlier this year.


Real-Time COVID R&D Tracking

As COVID-19 infections continue to spread, organizations with technologies or devices that can support new drug, vaccine, or test development have a life-saving contribution to make. The Amplion Intelligence Platform can alert you to new COVID-19 trial activities in real-time and automatically match you to partners who need your unique capabilities immediately. It’s already tomorrow somewhere, so let us help you start today.  Learn More

Request Access